Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Hoyd

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Biorxiv : the Preprint Server for Biology|November 18, 2024
Breast tumor microbiome regulates anti-tumor immunity and T cell-associated metabolitesChin-Chih Liu, Dennis Grencewicz, Karthik Chakravarthy, et al.
Journal of Cancer Research and Clinical Oncology|September 7, 2022
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survivalAbdul Miah, Gabriel Tinoco, Songzhu Zhao, et al.
International Journal of Molecular Sciences|December 23, 2022
Association between Tumor Microbiome and Hypoxia across Anatomic Subsites of Head and Neck CancersAastha Dhakal, Rituraj Upadhyay, Caroline Wheeler, et al.
Plos Computational Biology|August 23, 2021
Bayesian structural time series for biomedical sensor data: A flexible modeling framework for evaluating interventionsJason Liu, Daniel J Spakowicz, Garrett I Ash, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
The Association of the Microbiome with Melanoma Tumor Response to Immune Checkpoint Inhibitor Treatment and Immune-Related Adverse Events (NCT05102773)Caroline Dravillas, Nyelia Williams, Marium Husain, et al.
Journal of Geriatric Oncology|February 25, 2021
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancerAndrew C Johns, Lai Wei, Madison Grogan, et al.
Cancer Biology & Therapy|May 9, 2024
Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survivalRituraj Upadhyay, Aastha Dhakal, Caroline Wheeler, et al.
BMC Cancer|May 8, 2020
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medicationsDaniel Spakowicz, Rebecca Hoyd, Mitchell Muniak, et al.
HGG Advances|October 9, 2025
Colon cancer in Appalachian Kentucky: Unique genetic, microbiome and obesity findings in a cohort comparisonZeta Chow, Jinpeng Liu, Daheng He, et al.
Journal of Geriatric Oncology|August 22, 2024
Resiliency among older adults receiving lung cancer treatment (ROAR-LCT): A novel supportive care intervention for older adults with advanced lung cancerCarolyn J Presley, Madison Grogan, Amy Compston, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|November 18, 2024
Breast tumor microbiome regulates anti-tumor immunity and T cell-associated metabolitesChin-Chih Liu, Dennis Grencewicz, Karthik Chakravarthy, et al.
Journal of Cancer Research and Clinical Oncology|September 7, 2022
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survivalAbdul Miah, Gabriel Tinoco, Songzhu Zhao, et al.
International Journal of Molecular Sciences|December 23, 2022
Association between Tumor Microbiome and Hypoxia across Anatomic Subsites of Head and Neck CancersAastha Dhakal, Rituraj Upadhyay, Caroline Wheeler, et al.
Plos Computational Biology|August 23, 2021
Bayesian structural time series for biomedical sensor data: A flexible modeling framework for evaluating interventionsJason Liu, Daniel J Spakowicz, Garrett I Ash, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
The Association of the Microbiome with Melanoma Tumor Response to Immune Checkpoint Inhibitor Treatment and Immune-Related Adverse Events (NCT05102773)Caroline Dravillas, Nyelia Williams, Marium Husain, et al.
Journal of Geriatric Oncology|February 25, 2021
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancerAndrew C Johns, Lai Wei, Madison Grogan, et al.
Cancer Biology & Therapy|May 9, 2024
Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survivalRituraj Upadhyay, Aastha Dhakal, Caroline Wheeler, et al.
BMC Cancer|May 8, 2020
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medicationsDaniel Spakowicz, Rebecca Hoyd, Mitchell Muniak, et al.
HGG Advances|October 9, 2025
Colon cancer in Appalachian Kentucky: Unique genetic, microbiome and obesity findings in a cohort comparisonZeta Chow, Jinpeng Liu, Daheng He, et al.
Journal of Geriatric Oncology|August 22, 2024
Resiliency among older adults receiving lung cancer treatment (ROAR-LCT): A novel supportive care intervention for older adults with advanced lung cancerCarolyn J Presley, Madison Grogan, Amy Compston, et al.
Pageof 4